InNexus Biotechnology, Inc.
InNexus Biotechnology, Inc. (IXSBF) Revenue
Annual & quarterly revenue history · segment & region breakdown
IXSBF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsInNexus Biotechnology, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income InNexus Biotechnology, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
InNexus Biotechnology, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from InNexus Biotechnology, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
IXSBF revenue · 4 questionsIXSBF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · InNexus Biotechnology, Inc. SEC filings · GAAP · InNexus Biotechnology, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026